2019
DOI: 10.1186/s12888-019-2237-x
|View full text |Cite
|
Sign up to set email alerts
|

Clinical guidelines for the management of treatment-resistant depression: French recommendations from experts, the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental

Abstract: Background: Clear guidance for successive antidepressant pharmacological treatments for non-responders in major depression is not well established. Method: Based on the RAND/UCLA Appropriateness Method, the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental developed expert consensus guidelines for the management of treatment-resistant depression. The expert guidelines combine scientific evidence and expert clinicians' opinions to produce recommendations for … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
55
0
2

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 70 publications
(59 citation statements)
references
References 45 publications
2
55
0
2
Order By: Relevance
“…They also may signal risk of residual symptoms, such as sleep disturbances, executive impairments and anxiety [ 13 ]. They are considered by a group of experts as great indicators of prognosis and severity of TRD [ 14 16 ]. Identifying their relationship with cerebral functioning could improve resistance management and selection of potential cerebral therapeutic targets.…”
Section: Discussionmentioning
confidence: 99%
“…They also may signal risk of residual symptoms, such as sleep disturbances, executive impairments and anxiety [ 13 ]. They are considered by a group of experts as great indicators of prognosis and severity of TRD [ 14 16 ]. Identifying their relationship with cerebral functioning could improve resistance management and selection of potential cerebral therapeutic targets.…”
Section: Discussionmentioning
confidence: 99%
“…venlafaxine), as well as an increasing number of other types of recent antidepressants (such as bupropion and mirtazapine), besides the older tricyclic and monoamine oxidase inhibitor drugs [4][5][6][7][8][9].…”
mentioning
confidence: 99%
“…A recent systematic review did not reveal any guidelines developed specifically for TRD, 2 but in 2019, the French Association for Biological Psychiatry and Neuropsychopharmacology published “Clinical guidelines for the management of treatment-resistant depression”. 88 In addition, some MDD guidelines do contain recommendations for TRD diagnosis and treatment. 58 , 59 , 67 …”
Section: Resultsmentioning
confidence: 99%